Background: At-risk small-for-gestational age (SGA) pregnancies in New Zealand are identified using Doppler ultrasound; fetuses with Doppler abnormalities are considered growth restricted (FGR). Low maternal placental growth factor (PlGF) has also been associated with late-onset FGR.
INTRODUCTION
features of FGR are expectantly managed until 40 weeks gestation. While this ultrasound definition of FGR is consistent with international best practice, 3, 18 serial Doppler ultrasound examinations may not be available in some NZ centres.
Among late-onset SGA pregnancies, we aimed to explore the relationship between low PlGF (<5th percentile) and FGR defined by ultrasound (EFW <3rd centile and/or abnormal Doppler studies). We hypothesised that a low PlGF at diagnosis of suspected SGA would identify similar FGR pregnancies as ultrasound.
Additionally, among SGA pregnancies without features of FGR on initial ultrasound, we aimed to determine whether low PlGF would identify the same FGR pregnancies as serial Doppler measurements. Our secondary aim was to investigate the relationship between low PlGF and adverse pregnancy outcomes, including adverse perinatal outcome (operative delivery for fetal distress and/or evidence of birth asphyxia) and the development of gestational hypertensive disease.
MATERIALS AND METHODS
Prospectively collected data were used from an historical database of suspected SGA pregnancies in Auckland, New Zealand (ethics approval NTX/11/056/02 Northern Regional Ethics Committee). 19 Women were recruited between 1993 and 1997 if they had a singleton pregnancy with ultrasound evidence of suspected SGA (AC <10th percentile) and no evidence of fetal abnormality. UA Doppler resistance index (RI) was performed on entry into the study. After recruitment, additional Doppler studies were performed (including UA RI, internal carotid artery (ICA) RI and UtA RI), and growth scans were performed at two weekly intervals until birth. Ten millilitres of maternal venous blood was taken within two weeks of recruitment.
Women were excluded if they were hypertensive at the diagnosis of SGA, <32 weeks gestational age at the time of blood sampling, had incomplete data on UA Doppler or EFW, or if there was more than two weeks between ultrasound fetal biometry and blood sampling ( Figure 1 ). 
Management

Definitions
Ultrasound scans and Doppler studies were performed by trained sonographers in a clinical ultrasound department using a Diasonics Masters Series (Diasonic, Milpitas, CA, USA) or Toshiba 270 (Toshiba Medical Systems, Tokyo, Japan) ultrasound machine.
Doppler studies were performed with the patient semi-recumbent during fetal quiescence and apnoea. Mean RI was calculated from five waveforms. UA Doppler studies were considered abnormal if greater than the 95th percentile, 20 and ICA Doppler studies were considered abnormal if the RI was less than the 10th percentile for gestational age. 21 Mean RI of the right and left UtA were recorded and considered abnormal if greater than the 95th percentile for gestational age. 20 CPR was defined as the ratio between the ICA and UA Dopper RI and considered abnormal if the ratio was less than the 10th percentile.
22,23
Estimated fetal weight was calculated from fetal biometry using the Hadlock 4 Maternal venous blood was collected by a research midwife using 10 mL ethylenediaminetetraacetic acid plasma tubes, allowed to clot at 37°C for one hour and plasma was obtained through centrifugation before storage at −80°C.
Samples were subsequently batch assayed for PlGF using an automated immunoassay (Triage ® , Alere, San Diego, CA, USA).
Low PlGF was defined as a concentration <5th percentile for gestational age.
26
Gestational hypertension was a diastolic blood pressure ≥90 mmHg on more than two occasions at least six hours apart and pre-eclampsia was gestational hypertension with proteinuria of 2+ on dipstick or >0.3 g/24 h.
27
Detailed labour and perinatal outcomes were collected pro- 
Statistics
Student's t-test or the Mann-Whitney U-test and χ 2 or Fisher's exact test were used as appropriate. P-values of <0.05 were considered significant. Normally distributed data were reported using means with standard deviations, while non-normally distributed data were reported using medians with interquartile ranges.
Categorical data were reported using counts and proportions.
Sensitivity, specificity, positive and negative predictive values of PlGF <5th centile describing FGR were calculated with 95%
confidence intervals.
Statistical analysis was performed using SAS© 9.4 (SAS Institute inc., Cary, NC, USA).
F I G U R E 1
Flowchart of study population of women with suspected small-for-gestational age (SGA) pregnancies, defined as an abdominal circumference <10th centile. FGR, fetal growth restriction (abnormal umbilical artery Doppler resistance index and/or estimated fetal weight <3rd centile); PlGF, placental growth factor. *More than one exclusion may apply so numbers do not total.
Excluded*:
• PlGF not able to be tested n = 10 Initial study population n = 136
Suspected SGA n = 259 FGR on entry to study n = 56
Secondary study population n = 80
RESULTS
We identified 259 women with SGA pregnancies and maternal serum samples. After exclusions, the initial study population included 136 women ( Figure 1 ). Participants were enrolled at a mean gestational age of 33. Table 2 ). The sensitivity of PlGF <5th Women with low PlGF had high rates of subsequent gestational hypertensive disease (63.6%) with all cases of pre-eclampsia occurring in this group (Table 2) . At birth, two-thirds of low PlGF pregnancies had a birthweight <3rd customised centile, and onethird of low PlGF pregnancies experienced an adverse perinatal outcome; double the rate of the normal PlGF group (Table 2) .
While there were no significant differences by PlGF status in caesarean section prior to the onset of labour, (low PlGF 13.6% vs 5.4%, P = 0.07), rates of five minute Apgar score <7 (low PlGF 4.6% vs 1.1%, P = 0.21) or cord gas acidosis (low PlGF 4.6% vs 2.2%, P = 0.29), there was a non-significant trend toward more severe outcomes among the low PlGF group. The lack of significance of these results may be due to the small numbers in the study.
As initial FGR pregnancies were identified as high risk at SGA diagnosis, we investigated the role of PlGF to identify secondary FGR, that is FGR identified on subsequent scanning. Of 80 pregnancies, secondary FGR was diagnosed in a third (n = 27, 33.8%;
abnormal UtA RI n = 16, UA RI n = 8, ICA RI n = 8, and CPR n = 6) and a low PlGF was identified in 17 (21.3%). There were no significant differences in secondary FGR by PlGF status; however, there was again a trend toward a higher proportion of secondary FGR among the low PlGF group (low PlGF 47.1%, normal PlGF 30.2%, Table 3 Similar to the initial study population, pregnancies with low PlGF in the secondary study population were more likely to experience gestational hypertensive disease (low PlGF 58.8%, normal PlGF 12.7%, P < 0.01) and were more likely to be SGA at birth (low PlGF 88.2%, normal PlGF 54.0%, P = 0.01; Table 3 ). There were no differences in adverse perinatal outcome, but numbers were low.
Sensitivity analyses were performed, excluding those with missing ICA and/or UtA Dopplers (n = 11). No differences in statistical significance were seen, and negligible differences in test performance characteristics were observed. †Missing n = 10 (PlGF <5th centile n = 5, PlGF >5th centile n = 5). ‡Missing n = 2 (PlGF <5th centile n = 0, PlGF >5th centile n = 2). §Estimated fetal weight <3rd customised centile or abnormal Doppler (umbilical artery RI, internal carotid RI, cerebro-perfusion ratio or mean uterine artery RI). ¶Operative delivery for fetal distress and/or evidence of birth asphyxia (cord arterial pH <7.15 and base deficit >7 mEq/L, and/or Apgar score at five minutes <7). CPR, cerebral placental ratio; CS, caesarean section; ICA, internal carotid artery; IOL, induction of labour; EFW, estimated fetal weight; FGR, fetal growth restriction; PlGF, placental growth factor; RI, resistance index. †Missing n = 4 (PlGF <5th centile n = 3, PlGF>5th centile n = 1). ‡Abnormal Doppler RI (umbilical artery, internal carotid, cerebroperfusion ratio or mean uterine artery).
§Operative delivery for fetal distress and/or evidence of birth asphyxia (cord arterial pH <7.15 and base deficit >7 mEq/L, and/or Apgar score at five minutes <7).
DISCUSSION
In this historical cohort of late-onset SGA pregnancies, low PlGF identified pregnancies that were at risk of both severe growth restriction and adverse perinatal outcome, predominantly due to operative delivery for fetal distress. Low PlGF therefore identified a more severe FGR phenotype associated with poor placental function and subsequent intolerance of labour, consistent with the association previously seen between low PlGF and placental FGR. 16 Low PlGF was also strongly associated with the later development of gestational hypertensive diseases. 
Strengths
This cohort study had prospective collection of data including serial Doppler measurements linked with labour and birth outcome data and a biobank.
Limitations
Our data are historical, and are therefore limited to what was collected and part of clinical practice at that time. Doppler studies at that time utilised RI instead of pulsatility index (PI), which is now considered best practice. Additionally, fetal cerebral blood flow was assessed using ICA Doppler, while currently middle cerebral artery (MCA) Doppler studies are standard. However, blood flow through the ICA is a surrogate for MCA blood flow and a CPR of <1 is independent of Doppler measurement type (RI vs PI) and is associated with increased perinatal risk. 23 In our population a CPR <1 identified the same pregnancies as a CPR <10th centile.
The management of SGA pregnancies at the time of data collection was not standardised. In particular, an abnormal Doppler study did not necessarily necessitate elective delivery, although increased surveillance was common. As a result, analysis of outcomes by FGR status would be misleading as it does not reflect current obstetric practice. We were therefore unable to include a comparison of outcomes between FGR and low PlGF pregnancies.
Overall this study had low numbers, particularly among our secondary study population. A larger sample size would have allowed for more robust evaluation of outcomes; however, it is unlikely to have raised the test performance of PlGF to a point where it would be able to replace serial Doppler examinations.
CONCLUSION
We report that while low PlGF at the time of late-onset SGA diagnosis is associated with increased perinatal risk, it does not adequately identify at-risk FGR infants classified using detailed Doppler studies. The measurement of PlGF in these women therefore cannot be considered an adequate replacement for serial Doppler investigations. Low PlGF is strongly associated with subsequent development of gestational hypertensive disease and therefore may be of clinical utility. Due to the historical nature of these data, our findings should be confirmed by repeating this analysis in a contemporary cohort.
